ARWR - Arrowhead Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2019
30/09/2018
30/09/2017
30/09/2016
Total revenue
138,973
168,796
16,142
31,408
158.333
Operating expenses
Research development
95,495
81,049
52,969
31,690
41,454
Selling general and administrative
42,338
26,556
19,110
32,023
40,998
Total operating expenses
137,833
107,605
72,079
68,404
79,850
Operating income or loss
1,140
61,191
-55,936
-36,996
-79,692
Total other income/expenses net
-
-
439.634
2,203
-2,294
Income before tax
9,705
68,148
-54,448
-34,378
-81,721
Income tax expense
173.553
173.553
2.4
2.4
2.4
Income from continuing operations
9,531
67,975
-54,450
-34,380
-81,723
Net income
9,531
67,975
-54,450
-34,380
-81,723
Net income available to common shareholders
9,531
67,975
-54,450
-34,380
-81,723
Basic EPS
-
0.72
-0.65
-0.47
-1.34
Diluted EPS
-
0.69
-0.65
-0.47
-1.34
Basic average shares
-
93,859
83,638
73,899
61,051
Diluted average shares
-
98,608
83,638
73,899
61,051
EBITDA
-
65,630
-51,237
-32,305
-76,432
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more